Comparison of intravenous versus oral busulfan on the prognosis of paediatric patients with acute leukaemia undergoing haematopoietic stem cell transplantation

被引：0
|
作者：
Hamidieh, A. [1 ]
Behfar, M. [1 ]
Tayebi, S. [1 ]
Jalali, A. [1 ]
Aliabadi, L. Sharifi [1 ]
Hosseini, A. [1 ]
Basirpanah, S. [1 ]
Ghavamzadeh, A. [1 ]
机构：
[1] Univ Tehran Med Sci, Tehran, Iran
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [1] Intravenous busulfan in paediatric haematopoietic stem cell transplantation
    Kuskonmaz, B.
    Unal, S.
    Akan, A.
    Cetin, N.
    Akyol, F.
    Cetin, M.
    Tezcan, I.
    Uckan, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S304 - S304
  • [2] Intravenous versus oral busulfan pre-transplant test dose: an evaluation of pharmacokinetics in patients undergoing haematopoietic stem cell transplantation
    Esteves, I.
    Fernandes, J.
    Souza, F.
    Feitosa, A.
    Morelli, L.
    Kutner, J. M.
    Sobrinho, J.
    Rodrigues, M.
    Nakashima, S.
    Sugawara, E.
    Victor, E.
    Oliveira, J. S.
    Seber, A.
    Hamersclak, N.
    Kerbauy, F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S225 - S226
  • [3] Individualised high-dose busulfan in paediatric patients undergoing haematopoietic stem cell transplantation
    Badell, I
    Farré, R
    López, E
    Pardo, N
    Torrent, M
    Sánchez, A
    Losa, L
    Juanals, MT
    Clopés, A
    Cubells, J
    Mangues, MA
    BONE MARROW TRANSPLANTATION, 2004, 33 : S333 - S333
  • [4] Conditioning with busulfan and fludarabine for allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukaemia: a comparison to busulfan and cyclophosphamide
    Lee, S. H.
    Cheuh, H.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S139 - S139
  • [5] Autologous haematopoietic stem cell transplantation after myeloablative regimen with oral or intravenous busulfan in acute myeloid leukaemia - a single-centre experience
    Cioch, M.
    Jawniak, D.
    Kotwica, K.
    Wach, M.
    Manko, J.
    Walter-Croneck, A.
    Legiec, W.
    Dmoszynska, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S91 - S92
  • [6] Less veno-occlusive disease after intravenous versus oral busulfan for autologous haematopoietic stem cell transplantation: the Belgian paediatric experience
    Huybrechts, S. J.
    Beguin, Y.
    Bordon, V.
    Dresse, M.
    Dupont, S.
    Ferster, A.
    Laureys, G.
    Meyts, I.
    Renard, M.
    Vermylen, C.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S379 - S379
  • [7] Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Ghavamzadeh, A.
    Alimogaddam, K.
    Khatami, F.
    Gaffari, F.
    Ashuri, A.
    Mousavi, A.
    Iravani, M.
    Bahar, B.
    Jahani, M.
    Khodabande, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S133 - S134
  • [8] Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Mousavi, S.
    Alimoghaddam, K.
    khatami, F.
    Jahani, M.
    Iravani, M.
    Bahar, B.
    Khodabandeh, A.
    Jalali, A.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S381 - S382
  • [9] New drugs in haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia
    Balduzzi, Adriana
    Di Maio, Lucia
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 31 - 36
  • [10] Prevalence and risk factors of oral mucositis in paediatric patients undergoing haematopoietic stem cell transplantation
    Alhussain, Abdulmalik
    Alkhayal, Zikra
    Ayas, Mouhab
    Abed, Hassan
    ORAL DISEASES, 2022, 28 (03) : 657 - 669
12345